Blog
Amphastar Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Amphastar Pharmaceuticals, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose 5% to $183.9 million, while diluted EPS increased to $0.67 from $0.64
Atlanticus Q2 Earnings Call Highlights
Key Points
- Interested in Atlanticus Holdings Corporation? Here are five stocks we like better.
- Record second-quarter performance: Atlanticus increased net income attributable to common
Astrana Health Q2 Earnings Call Highlights
Key Points
- Interested in Astrana Health, Inc.? Here are five stocks we like better.
- Strong second-quarter results: Revenue rose 49% year over year to $973 million, adjusted EBITDA increased
Airbnb Q2 Earnings Call Highlights
Key Points
- Interested in Airbnb, Inc.? Here are five stocks we like better.
- Airbnb delivered a strong second quarter, with revenue up 17% year over year to $3.6 billion, gross booking value up
AerSale Q2 Earnings Call Highlights
Key Points
- Interested in AerSale Corporation? Here are five stocks we like better.
- Second-quarter results weakened sharply: Revenue fell to $70.9 million from $107.4 million, adjusted EBITDA
Franklin Covey Shares Framework to Turn Presentations Into Action
Key Points
- Interested in Franklin Covey Company? Here are five stocks we like better.
- Franklin Covey outlined a three-step presentation framework: develop the story around audience needs, design
Ardelyx Q2 Earnings Call Highlights
Key Points
- Interested in Ardelyx, Inc.? Here are five stocks we like better.
- Second-quarter product revenue reached a record $118 million, up 31% year over year, but Ardelyx lowered its 2026
Anadarko Petroleum Q2 Earnings Call Highlights
Key Points
- Interested in Anadarko Petroleum Co.? Here are five stocks we like better.
- Second-quarter performance improved: Net income rose to $12.2 million, adjusted EBITDA increased 4% to
Alarm.com Q2 Earnings Call Highlights
Key Points
- Interested in Alarm.com Holdings, Inc.? Here are five stocks we like better.
- Alarm.com exceeded second-quarter expectations, with SaaS and license revenue rising 11.1% to $188.8
Arcturus Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Arcturus Therapeutics Holdings Inc.? Here are five stocks we like better.
- ARCT-032 cystic fibrosis study remains on track: Phase II enrollment is active in the U.S
Apyx Medical Q2 Earnings Call Highlights
Key Points
- Interested in Apyx Medical Corporation? Here are five stocks we like better.
- Revenue rose 22% to $13.9 million in the second quarter, driven by a 28% increase in surgical aesthetics
Arteris Q2 Earnings Call Highlights
Key Points
- Interested in Arteris, Inc.? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 46% year over year to $24.1 million, while ACV plus royalties increased 44% to
Akamai Technologies Q2 Earnings Call Highlights
Key Points
- Interested in Akamai Technologies, Inc.? Here are five stocks we like better.
- Akamai’s Q2 revenue rose 5% to $1.1 billion, led by 39% growth in cloud infrastructure services to $99
Applied Optoelectronics Q2 Earnings Call Highlights
Key Points
- Interested in Applied Optoelectronics, Inc.? Here are five stocks we like better.
- Record growth and profitability: Second-quarter revenue reached $191.9 million, up 86% year over
MACOM Technology Solutions Q3 Earnings Call Highlights
Key Points
- Interested in MACOM Technology Solutions Holdings, Inc.? Here are five stocks we like better.
- Record third-quarter performance: MACOM’s revenue rose 35.8% year over year to $342.2
Montauk Renewables Q2 Earnings Call Highlights
Key Points
- Interested in Montauk Renewables, Inc.? Here are five stocks we like better.
- Montauk Renewables returned to profitability in Q2 2026: Revenue rose 19.7% year over year to $54.0
ATS Shareholders Back Board as Chair Maps Margin, M&A and Growth Plans
Key Points
- Interested in ATS Corporation? Here are five stocks we like better.
- Shareholders backed ATS’ board and leadership, electing all eight director nominees, reappointing Ernst & Young
Lexicon Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Lexicon Pharmaceuticals, Inc.? Here are five stocks we like better.
- Revenue fell sharply to $0.7 million from $28.9 million a year earlier, while Lexicon reported a
Lightbridge Q2 Earnings Call Highlights
Key Points
- Interested in Lightbridge Corporation? Here are five stocks we like better.
- Fuel testing advanced: Lightbridge removed its first irradiated fuel samples from Idaho National
MidCap Financial Investment Q2 Earnings Call Highlights
Key Points
- Interested in MidCap Financial Investment Corporation? Here are five stocks we like better.
- Credit markdowns drove a weak quarter: MFIC reported $0.40 in net investment income per
MKS Q2 Earnings Call Highlights
Key Points
- Interested in MKS Inc.? Here are five stocks we like better.
- MKS reported strong second-quarter results, with revenue of $1.25 billion, up 16% sequentially and 28% year over year
Liquidity Services Q3 Earnings Call Highlights
Key Points
- Interested in Liquidity Services, Inc.? Here are five stocks we like better.
- Liquidity Services delivered record fiscal Q3 results: GMV rose 10% year over year to $453 million
Liberty Latin America Q2 Earnings Call Highlights
Key Points
- Interested in Liberty Latin America Ltd.? Here are five stocks we like better.
- Liberty Latin America returned to operating growth in Q2, with revenue of $1.1 billion, rebased adjusted
Ligand Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Ligand Pharmaceuticals Incorporated? Here are five stocks we like better.
- Q2 results strengthened: Revenue rose 34% year over year to $64 million, royalty revenue
Thryv Launches AI Growth Platform to Help Local Businesses Capture More Leads
Key Points
- Interested in Thryv Holdings, Inc.? Here are five stocks we like better.
- Thryv launched its AI-enabled Growth Platform to help small and midsize service businesses improve online